|
Background:
Amey is originally from Mumbai, India.
He received a Bachelor of Chemical
Engineering degree from the Institute of
Chemical Technology, Mumbai (previously
a part of the University of Mumbai, UDCT),
in May 2010. As an undergraduate, Amey
presented a number of posters and papers
on a variety of topics such as
Artificial Photosynthesis,
zero-discharge bio-refineries and steam
reforming of methanol for PEM based fuel
cell devices using microchannel
reactors. For his senior year project,
Amey completed an extensive literature
survey on the developments in extraction
techniques for natural ingredients such
as turmeric, black pepper oil, linseed
oil, etc. Amey was admitted to the
University of Texas at Austin in Fall
2010 and is currently pursuing a Ph.D.
in Chemical Engineering as a graduate
student under the direction of Dr.
Nicholas Peppas.
Research Summary
The overall aim of my research is to develop carriers that can deliver poorly water-soluble drugs via an oral route of administration. The development of such carriers can prove to be an effective treatment modality for cancer and can improve patient comfort and quality of life, in addition to ensuring the delivery of chemotherapeutics specifically to the cells that are afflicted by the disease.
Intravenous administration of hydrophobic chemotherapeutics can result in potentially toxic systemic concentrations of therapeutics, causing several deleterious side effects and deterioration of patient quality of life. To remedy these shortcomings, we seek to investigate carriers that can enhance the therapeutic effect of hydrophobic chemotherapeutics, while minimizing side effects and be delivered orally. However, oral delivery of hydrophobic therapeutic agents involves a number of challenges that must be circumvented such as loading hydrophobic chemotherapeutics in conventional hydrophilic polymer carriers, protecting the therapeutic agent from the low pH and degradative enzymes of the stomach, and finally, absorption and transport across the lumen wall to desired cancerous location. We propose that polyanionic grafted polymeric nanoparticles can help achieve this objective. These pH-responsive nanoparticles can be incorporated with hydrophobic moieties to exhibit increased loading and release of the hydrophobic chemotherapeutics.
Publications:
A. S. Puranik, E. R. Dawson and N.A. Peppas, “Recent Advances in Drug Eluting Stents”,
International Journal of Pharmaceutics (link).
Bae H; Puranik AS; Gauvin R;
Edalat F; Carrillo-Conde B; Peppas N A;
Khademhosseini A, "Building functional
vascular networks within tissue
engineered constructs", Science
Translational Medicine (link).
|